The Myasthenia Gravis Foundation of America Inc, with EIN 13-5672224, is dedicated to finding a cure for myasthenia gravis and related disorders while enhancing treatment options and providing support to affected individuals. With an operating budget of $4.4 million and total revenue of $5.7 million for the 2024 filing year, the organization engages in research, education, community programs, and advocacy. It does not rely on any single funder for 50% or more of its revenue and can be accessed online at www.myasthenia.org.